BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3416742)

  • 1. Rebound hypertension during initiation of transdermal clonidine.
    Stewart M; Burris JF
    Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 3. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension.
    Burris JF; Papademetriou V; Wallin JD; Cook ME; Weidler DJ
    Am J Med; 1991 Jul; 91(1A):22S-28S. PubMed ID: 1867225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males.
    Schmidt GR; Schuna AA; Goodfriend TL
    J Clin Pharmacol; 1989 Feb; 29(2):133-9. PubMed ID: 2715369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal and oral clonidine.
    Lilja M; Juustila H; Sarna S; Jounela AJ
    Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind comparison of transdermal clonidine with oral propranolol.
    Franklin SS; Tonkon MJ; Kirschenbaum MA; Dobak JD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S244-7. PubMed ID: 2455188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal administration of clonidine: a new approach to antihypertensive therapy.
    Burris JF; Mroczek WJ
    Pharmacotherapy; 1986; 6(1):30-4. PubMed ID: 3952004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension by a new transdermal form of clonidine.
    Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
    J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal antihypertensive therapy: clinical and metabolic considerations.
    Weber MA
    Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound hypertension after discontinuation of transdermal clonidine therapy.
    Metz S; Klein C; Morton N
    Am J Med; 1987 Jan; 82(1):17-9. PubMed ID: 3026180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.